Vertex grew headcount 13% for the second straight year
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
PTC Therapeutics (PTCT) Gets a Buy from RBC Capital
In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price ...
Morgan Stanley Sticks to Their Buy Rating for Arcus Biosciences (RCUS)
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Arcus Biosciences (RCUS – Research Report), with a ...
ENDPOINTS NEWS16h
Pain biotech Lati­go eyes up to $150M raise fol­low­ing Ver­tex's land­mark FDA nod
Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves created by Vertex Pharmaceuticals' pain drug ...